Preparation of 18F-labeled muscarinic agonist with M2 selectivity.
Kiesewetter
D O
DO
Positron Emission Tomography Department, National Institutes of Health, Bethesda, Maryland 20892-1180.
Lee
J
J
Lang
L
L
Park
S G
SG
Paik
C H
CH
Eckelman
W C
WC
D000818:Animals; D001921:Brain / Q000378:metabolism; D017611:Fluorine Compounds / Q000138:chemical synthesis* / Q000494:pharmacology*; D005462:Fluorine Radioisotopes; D007553:Isotope Labeling; D007700:Kinetics; D018721:Muscarinic Agonists / Q000138:chemical synthesis* / Q000494:pharmacology*; D011725:Pyridines / Q000138:chemical synthesis* / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011976:Receptors, Muscarinic / Q000145:classification / Q000378:metabolism; D012680:Sensitivity and Specificity; D013830:Thiadiazoles / Q000138:chemical synthesis* / Q000494:pharmacology*; D014018:Tissue Distribution
D017611:Fluorine Compounds; D005462:Fluorine Radioisotopes; D018721:Muscarinic Agonists; D011725:Pyridines; D011976:Receptors, Muscarinic; D013830:Thiadiazoles